Up 15% In A Month: Barclays Plc Gets Its Bite Back

Barclays plc (LON: BARC) is finally beginning to show its teeth. You’d be barking not to buy it, Harvey Jones says.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

barclays

I hope you were paying attention when I wrote at the end of last year that Barclays (LSE: BARC) (NYSE: BCS.US) was the bank to watch in 2014. At the time, it traded at 251p. Today, it would cost you 296p, a leap of more than 15%. I suspected the market would come round to Barclays this year, but I didn’t expect it to happen so quickly.

I saw lots to like in Barclays at the end of last year. It has been quietly boosting is core tier 1 ratio, now 11.3%, and had just posted £4.97 billion of profit in Q3, despite the £741 million of costs of Project Transform. I especially liked the fact that the dividend was back, with Barclays forecast to yield 4% by the end of the year, and that the stock was trading at a tempting 8.3 times earnings.

January joy

So how did Barclays get its bite back? Well, January was quite a month. First, like the rest of the big banks, its share price benefited from publication of the Bank of England’s Bank Liabilities Survey, which showed a fall in their funding requirements and improvements in capital metrics and retail deposits. JP Morgan Cazenove then named Barclays as a top pick in the European investment banking sector. The entire sector got a further boost on Monday, after Basel III capital requirements were eased, in a bid to prevent a tightening in global finance. This persuaded Ian Gordon at Investec to issue a buy note for Barclays, saying it offered “further comfort around leverage ratio requirements”. Suddenly everybody wanted a piece of Barclays.

Barring accidents or black swans, I would expect Barclays to continue to grow this year, although not at the same pace. The UK economy is stuttering back to life and inflation is falling, which should make consumers feel a bit richer. The housing market is booming, and although I don’t expect that first base rate hike to come this year, 2015 is a distinct possibility. As Barclays beefs up its dividend, retail and institutional income investors will want to add it to their portfolios. 

Next stop: Barking

Inevitably, Barclays will cost you more than it did one month ago. Today, you pay 9.3 times earnings, rather than 8.3 times. In return, you get forecast earnings per share prospects of 23% in 2014 and 20% in 2015. The yield is forecast to be 5.1% by December 2015, which should make a lovely Christmas present. Barclays is hard to love, but at least it has got it bite back. I hope you listened to me when I was barking about it last month.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

> Harvey doesn’t hold shares in any company mentioned in this article.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »